← Browse by Condition
Medical Condition

sezary syndrome

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for sezary syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sezary syndrome Clinical Trials

How many clinical trials are currently recruiting for sezary syndrome?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for sezary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for sezary syndrome?
sezary syndrome research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a sezary syndrome clinical trial?
Eligibility criteria for sezary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Kyowa Kirin Co., Ltd. 1 trial
City of Hope Medical Center 1 trial

Recruiting Clinical Trials

NCT07132567
Recruiting
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Enrollment
15 pts
Location
South Korea
Sponsor
Kyowa Kirin Co., Ltd.
View Trial →
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
View Trial →

Related Conditions

mycosis fungoides (1) folliculotropic mycosis fungoides (1) primary cutaneous t cell non hodgkin lymphoma (1) stage ib mycosis fungoides and sezary syndrome ajcc v8 (1) stage ii mycosis fungoides and sezary syndrome ajcc v8 (1) stage iia mycosis fungoides and sezary syndrome ajcc v8 (1) stage iib mycosis fungoides and sezary syndrome ajcc v8 (1) transformed mycosis fungoides (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology